XML 49 R32.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
12 Months Ended
Jan. 06, 2022
Jan. 01, 2022
Jan. 01, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued, conversion of convertible securities       18,911    
Stock options outstanding       1,357,466 1,380,216  
Stock options outstanding weighted average exercise price       $ 7.39    
Stock options. intrinsic value       $ 0    
Options to purchase shares       12,500 145,750  
Weighted average period for unamortized stock compensation       3 years 4 months 13 days    
Warrant shares, outstanding       1,537,158 1,533,158 1,001,765
Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share based compensation expense       $ 20,433 $ 0  
Warrant shares, outstanding       1,537,158    
Warrant exercise price       $ 13.49    
Class of warrant or right, outstanding, intrinsic value       $ 0    
Option forfeited 4,000          
Warrants to purchase common stock 4,000          
Warrant term 5 years          
Warrant exercise price $ 5.00          
Employees [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share based compensation expense       182,748 769,479  
Unamortized stock option expense       8,566    
Non-Employees [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share based compensation expense       661,500 $ 749,277  
Unamortized stock option expense       $ 1,334,107    
Share-Based Payment Arrangement, Option [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock options outstanding       1,357,466 1,380,216 1,399,466
Stock options outstanding weighted average exercise price       $ 7.39 $ 7.36 $ 5.88
Options to purchase shares 12,500     12,500 145,750  
Stock options exercise price $ 4.84     $ 4.84 $ 19.08  
Share based compensation expense       $ 844,248 $ 1,518,756  
Stock options, fair value $ 68,614          
Stock options, weighted average remaining contractual term 10 years     5 years 4 months 28 days 6 years 3 months 25 days 6 years 5 months 23 days
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share based compensation expense       $ 747,830 $ 1,513,835  
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share based compensation expense       $ 96,418 $ 4,921  
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock options exercise price       $ 4.84    
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock options exercise price       $ 22.40    
Equity Option [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Unamortized stock option expense       $ 1,342,673    
2016 Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of additional shares granted   184,260 142,457      
Number of shares available for grant       1,543,872 1,359,612